uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Melphalan 200 mg/m2 with blood stem cell support as first-line myeloma therapy: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. Verksamhetsområde hematologi. (Blodsjukdomar)
2005 (English)In: Bone Marrow Transplant, ISSN 0268-3369, Vol. 35, no 10, 985-90 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 35, no 10, 985-90 p.
Keyword [en]
Adult, Aged, Female, Glomerular Filtration Rate, Hematopoietic Stem Cell Mobilization, Hematopoietic Stem Cell Transplantation/*adverse effects, Humans, Iohexol/pharmacokinetics, Male, Melphalan/*administration & dosage, Middle Aged, Multiple Myeloma/mortality/physiopathology/*therapy, Retrospective Studies
URN: urn:nbn:se:uu:diva-78305PubMedID: 15806125OAI: oai:DiVA.org:uu-78305DiVA: diva2:106218
Available from: 2006-05-15 Created: 2006-05-15 Last updated: 2011-01-11

Open Access in DiVA

No full text

Other links

By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 159 hits
ReferencesLink to record
Permanent link

Direct link